Depot-medroxyprogesterone acetate (DMPA)

medroxyprogesterone acetate · Pfizer

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Depot-medroxyprogesterone acetate (DMPA), covering 2015-06-04 to 2018-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis [Phase 2]